Skip to content

Clinical trials

Breast Neoplasms trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Country / region: Australia Clear all

378 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20015
20023
200312
20044
200511
200617
200712
200811
200917
20105
20118
201213
201318
201413
201513
20166
201716
201820
201915
202020
202119
202219
202325
202421
202529
202611

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed183
Recruiting71
Active, not recruiting64
Terminated37
Unknown status15
Not yet recruiting5
Approved for marketing3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche45
Novartis Pharmaceuticals31
Pfizer23
AstraZeneca22
Eli Lilly and Company20
ETOP IBCSG Partners Foundation15
Genentech, Inc.8
GlaxoSmithKline8
Sanofi7
Bristol-Myers Squibb5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms378
Neoplasm Metastasis46
Carcinoma, Non-Small-Cell Lung38
Ovarian Neoplasms36
Neoplasms35
Prostatic Neoplasms30
Colorectal Neoplasms28
Triple Negative Breast Neoplasms28
Stomach Neoplasms26
Endometrial Neoplasms25

Trials

Showing 26 to 50 of 378. Each trial links to its page on Pharma Observatory.

278 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.